These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33882723)

  • 1. Effect of taxifolin/dapagliflozin combination on colistin-induced nephrotoxicity in rats.
    Kabel AM; Salama SA
    Hum Exp Toxicol; 2021 Oct; 40(10):1767-1780. PubMed ID: 33882723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of diethyl nitrosamine-induced hepatocellular carcinoma by taxifolin and/or alogliptin: The interplay between toll-like receptor 4, transforming growth factor beta-1, and apoptosis.
    Kabel AM; Arab HH; Abd Elmaaboud MA
    Hum Exp Toxicol; 2021 Oct; 40(10):1710-1720. PubMed ID: 33840231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting oxidative stress, proinflammatory cytokines, apoptosis and toll like receptor 4 by empagliflozin to ameliorate bleomycin-induced lung fibrosis.
    Kabel AM; Estfanous RS; Alrobaian MM
    Respir Physiol Neurobiol; 2020 Feb; 273():103316. PubMed ID: 31600583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dapagliflozin improves steatohepatitis in diabetic rats via inhibition of oxidative stress and inflammation.
    Hazem RM; Ibrahim AZ; Ali DA; Moustafa YM
    Int Immunopharmacol; 2022 Mar; 104():108503. PubMed ID: 34998036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baicalein acts as a nephroprotectant that ameliorates colistin-induced nephrotoxicity by activating the antioxidant defence mechanism of the kidneys and down-regulating the inflammatory response.
    Dai C; Tang S; Wang Y; Velkov T; Xiao X
    J Antimicrob Chemother; 2017 Sep; 72(9):2562-2569. PubMed ID: 28859441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential protective effects of Dapagliflozin in gentamicin induced nephrotoxicity rat model via modulation of apoptosis associated miRNAs.
    Mohamed DI; Khairy E; Saad SST; Habib EK; Hamouda MA
    Gene; 2019 Jul; 707():198-204. PubMed ID: 31075409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, slows the progression of renal complications through the suppression of renal inflammation, endoplasmic reticulum stress and apoptosis in prediabetic rats.
    Jaikumkao K; Pongchaidecha A; Chueakula N; Thongnak LO; Wanchai K; Chatsudthipong V; Chattipakorn N; Lungkaphin A
    Diabetes Obes Metab; 2018 Nov; 20(11):2617-2626. PubMed ID: 29923295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dapagliflozin and/or L-arginine on solid tumor model in mice: The interaction between nitric oxide, transforming growth factor-beta 1, autophagy, and apoptosis.
    Kabel AM; Arab HH; Abd Elmaaboud MA
    Fundam Clin Pharmacol; 2021 Dec; 35(6):968-978. PubMed ID: 33609317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Catechin, Quercetin and Taxifolin on Redox Parameters and Metabolites Linked with Renal Health in Rotenone-toxified Rats.
    Crown OO; Ogundele OO; Akinmoladun AC; Famusiwa CD; Josiah SS; Olaleye MT; Akindahunsi AA
    Niger J Physiol Sci; 2019 Jun; 34(1):1-10. PubMed ID: 31449265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of taxifolin on cisplatin-associated oxidative optic nerve damage in rats.
    Ahiskali I; Ferah Okkay I; Mammadov R; Okkay U; Keskin Cimen F; Kurt N; Suleyman H
    Cutan Ocul Toxicol; 2021 Mar; 40(1):1-6. PubMed ID: 33121287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal protective effect of SGLT2 inhibitor dapagliflozin alone and in combination with irbesartan in a rat model of diabetic nephropathy.
    Abdel-Wahab AF; Bamagous GA; Al-Harizy RM; ElSawy NA; Shahzad N; Ibrahim IA; Ghamdi SSA
    Biomed Pharmacother; 2018 Jul; 103():59-66. PubMed ID: 29635129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment with the sodium glucose cotransporter 2 inhibitor, dapagliflozin, ameliorates glucose homeostasis and diabetic nephropathy in db/db mice.
    Terami N; Ogawa D; Tachibana H; Hatanaka T; Wada J; Nakatsuka A; Eguchi J; Horiguchi CS; Nishii N; Yamada H; Takei K; Makino H
    PLoS One; 2014; 9(6):e100777. PubMed ID: 24960177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent Treatment with Taxifolin and Cilostazol on the Lowering of β-Amyloid Accumulation and Neurotoxicity via the Suppression of P-JAK2/P-STAT3/NF-κB/BACE1 Signaling Pathways.
    Park SY; Kim HY; Park HJ; Shin HK; Hong KW; Kim CD
    PLoS One; 2016; 11(12):e0168286. PubMed ID: 27977755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol attenuates dapagliflozin-induced renal gluconeogenesis
    Sun X; Cao Z; Ma Y; Shao Y; Zhang J; Yuan G; Guo X
    Food Funct; 2021 Feb; 12(3):1207-1218. PubMed ID: 33432947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice.
    Wang D; Luo Y; Wang X; Orlicky DJ; Myakala K; Yang P; Levi M
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29301371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts.
    Lee TM; Chang NC; Lin SZ
    Free Radic Biol Med; 2017 Mar; 104():298-310. PubMed ID: 28132924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal outcomes with sodium glucose cotransporter 2 (SGLT2) inhibitor, dapagliflozin, in obese insulin-resistant model.
    Jaikumkao K; Pongchaidecha A; Chueakula N; Thongnak L; Wanchai K; Chatsudthipong V; Chattipakorn N; Lungkaphin A
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2021-2033. PubMed ID: 29572114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine?
    Ozyilmaz E; Ebinc FA; Derici U; Gulbahar O; Goktas G; Elmas C; Oguzulgen IK; Sindel S
    Intensive Care Med; 2011 Jan; 37(1):141-6. PubMed ID: 20845026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dapagliflozin not only improves hepatic injury and pancreatic endoplasmic reticulum stress, but also induces hepatic gluconeogenic enzymes expression in obese rats.
    Swe MT; Thongnak L; Jaikumkao K; Pongchaidecha A; Chatsudthipong V; Lungkaphin A
    Clin Sci (Lond); 2019 Dec; 133(23):2415-2430. PubMed ID: 31769484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury.
    Chang YK; Choi H; Jeong JY; Na KR; Lee KW; Lim BJ; Choi DE
    PLoS One; 2016; 11(7):e0158810. PubMed ID: 27391020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.